Comparative study of iron sucrose and ferric carboxymaltose in moderate iron deficiency anaemia in postnatal mothers in a tertiary care hospital: A randomized control study
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Background : Anaemia during the postnatal period is a significant worldwide health issue affecting 25% of cases, the most prevalent being iron deficiency anaemia. Parenteral iron therapy can diminish the probability of morbidity in postpartum mothers and timely intervention might subsequently reduce the load on the healthcare sector by decreasing difficulties during a crucial phase of maternal-infant interaction. Aim and Objectives : To assess the efficacy and safety of intravenous ferric carboxymaltose and intravenous iron sucrose for the treatment of moderate iron deficiency anaemia among postpartum mothers. Materials and Methods : This randomized control study was conducted at tertiary care hospital at Department of Obstetrics & Gynecology, Government Medical College Tiruppur for a period of 6 months from August 2024 – January 2025. A total of 100 post-natal mothers who were diagnosed with moderate iron deficiency anaemia after delivery were enrolled in this study. They were divided into two equal groups with Group A receiving iron sucrose and Group B receiving ferric carboxymaltose. After getting informed written consent, the following data were collected including age, medical history, obstetric history, and family history and treatment history. The pre treatment and the post treatment Hb levels were recorded. The data’s entered in Microsoft Excel and analysed using SPSS version 22.0 with appropriate statistical method. Results : Among the 100 study participants, most of the participants in both groups were in the age range of 26 to 30 with the mean age of the participants was 26.8 ± 4.1 in Group A and 26.2 ± 3.9 in Group B. The mean Hb in Group A (iron sucrose) was 8.4 g/dl before treatment and after treatment there is a rise of 10.1g/dl with mean rise of 1.7g/dl. The mean Hb in Group B (ferric carboxymaltose) was 8.3 g/dl before treatment and after treatment there is a rise of 11.2 g/dl with the mean rise of 2.9 g/dl. The mean rise of Hb in fcm group is statistically significant as p value <0.05. In Group A (iron sucrose)5 PN mothers had mild anaphylactic reactions like chills, rigor and nausea. In Group B (ferric carboxymaltose )1 PN mother had nausea and no anaphylactic reactions which shows ferric carboxymaltose had very minimal side effects. Conclusion : Ferric carboxymaltose increases haemoglobin levels and replenishes iron reserves more rapidly than intravenous iron sucrose and oral iron, without any major adverse events.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: iron deficiency anemia, postpartum anemia, iron sucrose, ferric carboxymaltose, parenteral iron therapy, intravenous iron, hemoglobin response, anaphylaxis, drug safety, postpartum women, iron supplementation, maternal outcomes, maternal mortality risk, postpartum depression risk, postpartum depression
Open Access status: hybrid
OpenAlex ID: W7235191353
